vs
Side-by-side financial comparison of LENZ Therapeutics, Inc. (LENZ) and Metalpha Technology Holding Ltd (MATH). Click either name above to swap in a different company.
LENZ Therapeutics, Inc. is the larger business by last-quarter revenue ($12.5M vs $12.0M, roughly 1.0× Metalpha Technology Holding Ltd). Metalpha Technology Holding Ltd runs the higher net margin — -24.0% vs -133.6%, a 109.6% gap on every dollar of revenue.
LENZ Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing novel ophthalmic therapies. Its lead product candidates address presbyopia, the age-related loss of near vision, catering to global patient groups with unmet medical needs in the eye care sector.
Metalpha Technology Holding LtdMATHEarnings & Financial Report
Metalpha Technology Holding Ltd is a global fintech firm specializing in digital asset wealth management, institutional-grade crypto investment services, and Web3 ecosystem infrastructure support. It serves professional investors, financial institutions, and high-net-worth clients across Asia, North America and Europe, with core segments including structured digital asset products, risk management solutions and DeFi technology development.
LENZ vs MATH — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.5M | $12.0M |
| Net Profit | $-16.7M | $-2.9M |
| Gross Margin | — | 28.3% |
| Operating Margin | -151.1% | -24.2% |
| Net Margin | -133.6% | -24.0% |
| Revenue YoY | — | -39.0% |
| Net Profit YoY | -63.5% | -147.7% |
| EPS (diluted) | $-0.59 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $12.5M | $12.0M | ||
| Q2 25 | $5.0M | — | ||
| Q1 25 | — | $24.8M | ||
| Q3 24 | $0 | $19.7M | ||
| Q2 24 | $0 | — |
| Q3 25 | $-16.7M | $-2.9M | ||
| Q2 25 | $-14.9M | — | ||
| Q1 25 | — | $9.8M | ||
| Q3 24 | $-10.2M | $6.0M | ||
| Q2 24 | $-10.3M | — |
| Q3 25 | — | 28.3% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 85.7% | ||
| Q3 24 | — | 49.5% | ||
| Q2 24 | — | — |
| Q3 25 | -151.1% | -24.2% | ||
| Q2 25 | -337.1% | — | ||
| Q1 25 | — | 39.3% | ||
| Q3 24 | — | 38.9% | ||
| Q2 24 | — | — |
| Q3 25 | -133.6% | -24.0% | ||
| Q2 25 | -298.2% | — | ||
| Q1 25 | — | 39.6% | ||
| Q3 24 | — | 30.7% | ||
| Q2 24 | — | — |
| Q3 25 | $-0.59 | $-0.07 | ||
| Q2 25 | $-0.53 | — | ||
| Q1 25 | — | $0.25 | ||
| Q3 24 | $-0.38 | $0.16 | ||
| Q2 24 | $-0.40 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.4M | $10.1M |
| Total DebtLower is stronger | — | $101.2K |
| Stockholders' EquityBook value | $193.9M | $35.1M |
| Total Assets | $210.7M | $413.8M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $25.4M | $10.1M | ||
| Q2 25 | $37.6M | — | ||
| Q1 25 | — | $6.9M | ||
| Q3 24 | $41.0M | $3.8M | ||
| Q2 24 | $84.0M | — |
| Q3 25 | — | $101.2K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $188.0K | ||
| Q3 24 | — | $275.1K | ||
| Q2 24 | — | — |
| Q3 25 | $193.9M | $35.1M | ||
| Q2 25 | $206.4M | — | ||
| Q1 25 | — | $36.6M | ||
| Q3 24 | $215.3M | $25.3M | ||
| Q2 24 | $192.9M | — |
| Q3 25 | $210.7M | $413.8M | ||
| Q2 25 | $217.3M | — | ||
| Q1 25 | — | $246.8M | ||
| Q3 24 | $224.0M | $237.2M | ||
| Q2 24 | $202.6M | — |
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.01× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.6M | $3.3M |
| Free Cash FlowOCF − Capex | $-9.0M | — |
| FCF MarginFCF / Revenue | -72.2% | — |
| Capex IntensityCapex / Revenue | 3.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-47.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-8.6M | $3.3M | ||
| Q2 25 | $-11.5M | — | ||
| Q1 25 | — | $16.2M | ||
| Q3 24 | $-10.6M | $-16.1M | ||
| Q2 24 | $-15.8M | — |
| Q3 25 | $-9.0M | — | ||
| Q2 25 | $-11.7M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-10.8M | — | ||
| Q2 24 | $-15.9M | — |
| Q3 25 | -72.2% | — | ||
| Q2 25 | -235.0% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | 3.5% | — | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.64× | ||
| Q3 24 | — | -2.66× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
